Safety of COVID-19 vaccines: spotlight on neurological complications
G Tondo, E Virgilio, A Naldi, A Bianchi, C Comi - Life, 2022 - mdpi.com
The COVID-19 pandemic has led to unprecedented demand on the global healthcare
system. Remarkably, at the end of 2021, COVID-19 vaccines received approvals for human …
system. Remarkably, at the end of 2021, COVID-19 vaccines received approvals for human …
Neurological disorders following COVID-19 vaccination
Y Yang, L Huang - Vaccines, 2023 - mdpi.com
Nowadays, people all over the world have been receiving different types of coronavirus
disease 2019 (COVID-19) vaccines. While their effectiveness has been well recognized …
disease 2019 (COVID-19) vaccines. While their effectiveness has been well recognized …
Blood coagulation and thrombotic disorders following SARS-CoV-2 infection and COVID-19 vaccination
Although abundant data confirm the efficacy and safety profile of the developed vaccines
against COVID-19, there are still some concerns regarding vaccination in high-risk …
against COVID-19, there are still some concerns regarding vaccination in high-risk …
Anticoagulation for the treatment of septic cerebral venous sinus thrombosis in the setting of pediatric sinogenic and otogenic intracranial infections
PA Sutter, MG Anderson, R Sahyouni, J Plonsker… - Neurosurgical …, 2023 - thejns.org
OBJECTIVE Septic cerebral venous sinus thrombosis (CVST) is a recognized complication
of pediatric sinogenic and otogenic intracranial infections. The optimal treatment paradigm …
of pediatric sinogenic and otogenic intracranial infections. The optimal treatment paradigm …
Comparative risk of cerebral venous sinus thrombosis (CVST) following COVID-19 vaccination or infection: A national cohort study using linked electronic health …
C Ohaeri, DR Thomas, J Salmon, S Cottrell… - Human Vaccines & …, 2022 - Taylor & Francis
To inform the public and policy makers, we investigated and compared the risk of cerebral
venous sinus thrombosis (CVST) after SARS-Cov-2 vaccination or infection using a national …
venous sinus thrombosis (CVST) after SARS-Cov-2 vaccination or infection using a national …
Cerebral venous thrombosis: a practical review
A Borhani-Haghighi… - Postgraduate Medical …, 2024 - academic.oup.com
The evolution of the Coronavirus Disease-2019 pandemic and its vaccination raised more
attention to cerebral venous thrombosis (CVT). Although CVT is less prevalent than arterial …
attention to cerebral venous thrombosis (CVT). Although CVT is less prevalent than arterial …
Nationwide Cohort observational study on the safety and efficacy of COVID-19 vaccination in patients with Moyamoya disease
The safety and efficacy of coronavirus disease 2019 (COVID-19) vaccination in patients
diagnosed with Moyamoya disease (MMD) have not been established. Using National …
diagnosed with Moyamoya disease (MMD) have not been established. Using National …
Cerebral Venous Sinus Thrombosis
VN Nguyen, AN Demetriou, J Dallas… - Neurosurgery …, 2024 - neurosurgery.theclinics.com
Cerebral venous sinus thrombosis (CVST) is a rare type of stroke characterized by the
formation of blood clots within the dural venous sinuses, which are large venous conduits …
formation of blood clots within the dural venous sinuses, which are large venous conduits …
Intracranial venous sinus thrombosis: Medical and surgical management considerations
Cerebral venous thrombosis is a serious neurological condition characterized by thrombus
formation in the venous sinuses or cerebral veins. Although rare, it is a potentially fatal …
formation in the venous sinuses or cerebral veins. Although rare, it is a potentially fatal …
[HTML][HTML] Extensive cerebral venous sinus thrombosis post COVID-19 vaccination
Extensive cerebral sinus thrombosis following severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) vaccination is rare. We report the case of a 42-year-old man …
coronavirus 2 (SARS-CoV-2) vaccination is rare. We report the case of a 42-year-old man …